GlucoTrack (NASDAQ:GCTK) Trading Up 9% – What’s Next?

GlucoTrack, Inc. (NASDAQ:GCTKGet Free Report)’s stock price shot up 9% during mid-day trading on Wednesday . The company traded as high as $0.35 and last traded at $0.3477. 262,735 shares were traded during trading, a decline of 70% from the average session volume of 864,733 shares. The stock had previously closed at $0.3190.

Wall Street Analyst Weigh In

GCTK has been the subject of several recent research reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of GlucoTrack in a research note on Tuesday, April 21st. Wall Street Zen upgraded GlucoTrack to a “sell” rating in a research note on Saturday, May 30th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock has an average rating of “Sell”.

Read Our Latest Analysis on GCTK

GlucoTrack Trading Up 9.0%

The firm’s 50-day moving average price is $0.57 and its 200 day moving average price is $1.70. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.08. The company has a market cap of $2.18 million, a price-to-earnings ratio of -0.02 and a beta of 0.77.

Institutional Investors Weigh In On GlucoTrack

A number of institutional investors have recently added to or reduced their stakes in the company. Bank of America Corp DE boosted its position in GlucoTrack by 102,125.0% in the second quarter. Bank of America Corp DE now owns 4,089 shares of the company’s stock worth $25,000 after purchasing an additional 4,085 shares during the last quarter. Boothbay Fund Management LLC bought a new stake in shares of GlucoTrack during the 4th quarter worth $52,000. Finally, Ikarian Capital LLC bought a new stake in shares of GlucoTrack during the 4th quarter worth $177,000. 10.92% of the stock is owned by institutional investors.

About GlucoTrack

(Get Free Report)

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc and changed its name to GlucoTrack, Inc in November 2021. GlucoTrack, Inc was founded in 2001 and is based in Rutherford, New Jersey.

See Also

Receive News & Ratings for GlucoTrack Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlucoTrack and related companies with MarketBeat.com's FREE daily email newsletter.